Axogen, Inc. — Director's Dealing 2021

Aug 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2021-08-12

Reporting Person: Zaderej Karen L. (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-12	Common Stock	M	8254	$5.09	Acquired	822272	Direct
2021-08-13	Common Stock	M	46500	$3.67	Acquired	868772	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-12	Employee Stock Option (right to buy)	$5.09	M	8254	Disposed	2022-12-28	Common Stock (8254.0)	Direct
2021-08-13	Employee Stock Option (right to buy)	$3.67	M	46500	Disposed	2021-12-29	Common Stock (46500.0)	Direct

Footnotes

F1: The Reporting Person has elected to exercise and hold the shares at this time.

F2: All shares of Common Stock underlying the employee stock option became fully vested on December 28, 2019 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 28, 2016 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.

F3: All shares of Common Stock underlying the employee stock option became fully vested on December 29, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.